Bentham Science Logo

Track Your Manuscript:


Letters in Drug Design & Discovery

Volume 17, 12 Issues, 2020
ISSN: 1875-628X (Online)
ISSN: 1570-1808 (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Letters in Drug Design & Discovery, Volume 2 - Number 5


Symmetrical Derivatives with Nitrogenated Functions as Cytotoxic Agents and Apoptosis Inducers

, 2(5): 341 - 354

Carmen Sanmartin, Elena Ardaiz, Lucia Cordeu, Elena Cubedo, Jesus Garcia-Foncillas, Maria Font and Juan Antonio Palop


DOI: 10.2174/1570180054405794








M2000, Foundation of a New Generation Among NSAIDs

, 2(5): 412 - 423

A. Mirshafiey, B. Rehm, S. Cuzzocrea, H. Matsuo, E. Mazzon, S. Nakane, C- S. Koh and S. Miyoshi


DOI: 10.2174/1570180054405767


Aromatic Polycationic Molecules with Restricted Conformations: An Alternative Approach to Antiherpes Agents

, 2(5): 424 - 427

Andrew Tsotinis, Margarita Vlachou, Andreas Eleutheriades, Peter J. Garratt, Ashley J. Ibbett, Yiu-Fai Ng, Christophe Pannecouque, Myriam Witvrouw and Erik De Clercq


DOI: 10.2174/1570180054405758




Editor-in-Chief

K. Kuca
University of Hradec Kralove
Hradec Kralove
(Czech Republic)

Biography
View Full Editorial Board

Journal History

Letters in Drug Design & Discovery was introduced in 2004. Dr. Kamil Kuca serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.05

Advertisement

How to write and publish your papers in high impact journalsCovid Resource Center

Related Journals

Related eBooks

eBooks Catalog